Peptide record

TPDB25945

Antibacterial Toxicity standard
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB25945
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 22-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
TRRKWWKKVLNGAIKIAPYILD
Physicochemical Analysis
C127H205N35O28
CEQHMFS
K
2670.24
11.02
6
1
11
+5
0.87
-0.386
110.91
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
12490
467.75
3
Residue Composition
number
2
A
2
R
1
N
1
D
0
C
0
E
0
Q
1
G
0
H
3
I
2
L
4
K
0
M
0
F
1
P
0
S
1
T
2
W
1
Y
1
V
Amino Acid Distribution
A: 2 R: 2 N: 1 D: 1 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 2 K: 4 M: 0 F: 0 P: 1 S: 0 T: 1 W: 2 Y: 1 V: 1
Chemical Descriptors
22
C127H205N35O28
2670.24
11.02
+5
0.87
-0.386
Evidence Records 10 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

Active against E-faecium (MIC >64 uM), S. aureus (MIC 1 uM), K. pneumoniae (MIC 0.5 uM), A. baumannii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloa
Evidence 2 Activity

Activity

MIC
Antibacterial
0.5 µM

Target

Klebsiella pneumoniae

Source & Reference

NA

Other

Active against E-faecium (MIC >64 uM), S. aureus (MIC 1 uM), K. pneumoniae (MIC 0.5 uM), A. baumannii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (M
Evidence 3 Activity

Activity

MIC
Antibacterial
0.5 µM

Target

A. baumannii

Source & Reference

NA

Other

Active against E-faecium (MIC >64 uM), S. aureus (MIC 1 uM), K. pneumoniae (MIC 0.5 uM), A. baumannii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 4 uM), S. Typhimurium (M
Evidence 4 Activity

Activity

MIC
Antibacterial
1 µM

Target

Pseudomonas aeruginosa

Source & Reference

NA

Other

MIC >64 uM), S. aureus (MIC 1 uM), K. pneumoniae (MIC 0.5 uM), A. baumannii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 4 uM), S. Typhimurium (MIC 0.5 uM), and P. vulgari
Evidence 5 Activity

Activity

MIC
Antibacterial
0.5 µM

Target

Enterobacter cloacae

Source & Reference

NA

Other

C 1 uM), K. pneumoniae (MIC 0.5 uM), A. baumannii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 4 uM), S. Typhimurium (MIC 0.5 uM), and P. vulgaris (MIC 8 uM). Also inhibi
Evidence 6 Activity

Activity

MIC
Antibacterial
4 µM

Target

Escherichia coli

Source & Reference

NA

Other

IC 0.5 uM), A. baumannii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 4 uM), S. Typhimurium (MIC 0.5 uM), and P. vulgaris (MIC 8 uM). Also inhibit biofilm formation.
Evidence 7 Activity

Activity

MIC
Antibacterial
0.5 µM

Target

S. Typhimurium

Source & Reference

NA

Other

nnii (MIC 0.5 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 4 uM), S. Typhimurium (MIC 0.5 uM), and P. vulgaris (MIC 8 uM). Also inhibit biofilm formation.
Evidence 8 Activity

Activity

MIC
Antibacterial
8 µM

Target

P. vulgaris

Source & Reference

NA

Other

(MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 4 uM), S. Typhimurium (MIC 0.5 uM), and P. vulgaris (MIC 8 uM). Also inhibit biofilm formation.
Evidence 9 Activity

Activity

45% Cytotoxicity
Toxicity
10 µM
Cytotoxic
45% Cytotoxicity | 10 | µM | target cell: Human bronchial epithelial cells 16HBE14o-

Target

Human bronchial epithelial cells 16HBE14o-

Source & Reference

NA
DBAASP
Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens. | Antibiotics (Basel) | 2022
Evidence 10 Activity

Activity

45% Cytotoxicity
Toxicity
10 µM
Cytotoxic
45% Cytotoxicity | 10 | µM | target cell: Human PBMC

Target

Human PBMC

Source & Reference

NA
DBAASP
Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens. | Antibiotics (Basel) | 2022